ELITE PHARMACEUTICALS INC /NV/ (ELTP)

OTC Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$21.6M
Cash & Equivalents
$14.6M
Quarterly Burn Rate
$369M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

No upcoming catalysts detected for this company.

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT06869785 Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab PHASE3 Active Not Recruiting 196

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for ELTP.

SEC EDGAR Filings

All SEC filings for ELITE PHARMACEUTICALS INC /NV/ on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.